A real-world pharmacovigilance analysis of cardiac adverse events associated with newer antibody-drug conjugates for hematological malignancies in adults: A disproportionality analysis from FDA adverse event reporting system database

Journal of Oncology Pharmacy Practice · Published 2026-07-31 · DOI 10.1177/10781552261470082

Authors (5)

Deepika Dilip, Pritika Sharma, Elizabeth Drugge, Arpita Pawa, Amir Steinberg

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dilip, D., Sharma, P., Drugge, E., et al. (2026). A real-world pharmacovigilance analysis of cardiac adverse events associated with newer antibody-drug conjugates for hematological malignancies in adults: A disproportionality analysis from FDA adverse event reporting system database. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261470082

Related articles

• Medication review in cancer pain management: A patient safety framework for optimizing pain control and reducing medication-related harm/adverse drug events · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Remote collection of patient-reported quality of life outcomes via text messaging in cancer patients receiving oral anti-cancer therapy · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Updates in the pharmacologic management of various Castleman disease subtypes: A comprehensive review · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Clinical outcomes in HTA appraisal reports of oncology medicines in Portugal: A cross-sectional analysis · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Failure mode and effects analysis of hazardous drugs preparation workflows using isolators with contextual evaluation of laminar airflow cabinets in hospital pharmacy · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Pharmaceutical services in pediatric oncology: A scoping review · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Pharmacology-Guided venetoclax dose reduction with azacitidine in older or unfit acute myeloid leukemia: A North African experience from a Moroccan single-center cohort and exploratory hospital cost-effectiveness analysis · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Long term stability study of cisplatin in polyolefin infusion bags in dose banding conditions using eco-friendly hydrophilic interaction chromatography and colorimetry methods · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Practical considerations in the management of patients with atrial fibrillation/flutter and hematologic malignancies · Journal of Oncology Pharmacy Practice · 2026 · Same journal
• Personalised treatment in hpv-positive oropharyngeal squamous cell cancer: Insights from molecular biology to clinical trials · Journal of Oncology Pharmacy Practice · 2026 · Same journal